Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Innoveren Scientific Inc (IVRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2022	12-2021	12-2020	12-2019	12-2018
Cash Flows From Operating Activities
Net Income	-10,300	-4,799	-6,459	-29,808	-4,394
Depreciation Amortization	-485	16	1,477	987	95
Accounts receivable	-54	-6	13	35	2
Accounts payable and accrued liabilities	365	-422	-479	122	-41
Other Working Capital	464	-760	-187	-98	148
Other Operating Activity	8,097	1,161	-1,623	16,472	646
Operating Cash Flow	$-1,914	$-4,810	$-7,258	$-12,291	$-3,545

Cash Flows From Investing Activities
PPE Investments	N/A	-8	-2	-90	-11
Net Acquisitions	1	N/A	N/A	-303	N/A
Purchase Sale Intangibles	N/A	N/A	N/A	N/A	-12
Other Investing Activity	0	0	0	0	-12
Investing Cash Flow	$1	$-8	$-2	$-393	$-23

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	N/A	N/A	1,635	936
Debt Issued	530	3,325	4,652	N/A	4,306
Debt Repayment	-137	-53	N/A	N/A	N/A
Common Stock Issued	1,425	N/A	N/A	6,951	N/A
Dividend Paid	N/A	N/A	N/A	-15	N/A
Other Financing Activity	0	0	2,825	5,467	-1,856
Financing Cash Flow	$1,818	$3,272	$7,477	$14,039	$3,386

Beginning Cash Position	95	1,641	1,424	70	251
End Cash Position	N/A	95	1,641	1,424	70
Net Cash Flow	$-95	$-1,546	$217	$1,355	$-182

Free Cash Flow
Operating Cash Flow	-1,914	-4,810	-7,258	-12,291	-3,545
Capital Expenditure	N/A	-8	-2	-90	-11
Free Cash Flow	-1,914	-4,818	-7,260	-12,382	-3,556